TABLE OF CONTENTS
Volume 3, Issue 4 (July 2006)
Papers |
US Case Reports |
EU Case Reports |
US Legal Regulatory Update |
Patent Expiry Impact Predictor
US Case Reports |
EU Case Reports |
US Legal Regulatory Update |
Patent Expiry Impact Predictor
Top of page
Top of page
Top of page
Top of page
Top of page
Papers
Sustaining generic medicines markets in Europe
Steven Simoens and Sandra De Coster
J Generic Med 3: 257-268; doi:10.1057/palgrave.jgm.4940128
The changing competitive landscape in the global generics market: Threat or opportunity?
Vijay Karwal
J Generic Med 3: 269-279; doi:10.1057/palgrave.jgm.4940129
Drug master file review issues at the Office of Generic Drugs
Paul Schwartz
J Generic Med 3: 280-286; doi:10.1057/palgrave.jgm.4940130
The future of generics in Brazil
Faiz Kermani
J Generic Med 3: 287-294; doi:10.1057/palgrave.jgm.4940131
The evolution of the global active pharmaceutical ingredients supply market and the impact on the generic pharmaceuticals business in the United States
Ambrose Stafford
J Generic Med 3: 295-305; doi:10.1057/palgrave.jgm.4940132
US Case Reports
US Case Reports: Teva v FDA and Apotex v FDA: Two Court Decisions on the interpretation of a 'Court Decision'
Frederick H Rein and Amanda M Kessel
J Generic Med 3: 306-313; doi:10.1057/palgrave.jgm.4940133
EU Case Reports
Evergreening – extending patent life and curbs on repackaging
Rebecca Halford-Harrison
J Generic Med 3: 314-319; doi:10.1057/palgrave.jgm.4940134
US Legal Regulatory Update
The defence of inequitable conduct in 2006: A review of inequitable conduct cases and a preview of proposed changes
Azy S Kokabi, Caitlin Lhommedieu and Paul A Braier
J Generic Med 3: 320-327; doi:10.1057/palgrave.jgm.4940135
